List of insiders holdings for bluebird bio Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Polack Axel Director |
2013-06-26 16:55:47 | 0 2,431,633 |
2,431,633 | Form 4 |
2 | TVM V LIFE SCIENCE VENTURES GMBH & CO KG TVM Capital GmbH Polack Axel SCHUHSLER HELMUT Goll Alexandra Birner Hubert Fischer Stefan 10% Owner |
2013-06-24 17:45:13 | 2,431,633 0 |
2,431,633 | Form 4 |
3 | TEPPER ROBERT I Director 10% Owner |
2015-02-04 16:34:29 | 151,496 1,816,780 |
1,968,276 | Form 4 |
4 | Mulder Geert-Jan Director |
2013-06-26 16:52:28 | 0 1,251,526 |
1,251,526 | Form 4 |
5 | Leschly Nick Director |
2024-11-08 16:09:06 | 365,689 168,699 |
534,388 | Form 4 |
6 | GILLIS STEVEN Director |
2015-07-30 16:38:11 | 23,759 323,675 |
347,434 | Form 4 |
7 | Gregory Philip D Chief Scientific Officer |
2021-11-17 08:58:15 | 206,615 0 |
206,615 | Form 4 |
8 | Krawtschuk Christopher Chief Financial Officer |
2024-03-05 17:39:56 | 199,000 0 |
199,000 | Form 4 |
9 | Cole Jason Chief Strategy & Financial Off |
2022-08-23 16:50:07 | 189,546 0 |
189,546 | Form 4 |
10 | Consylman Gina Chief Financial Officer |
2022-02-03 18:07:58 | 175,385 0 |
175,385 | Form 4 |
11 | Baird William D III Chief Financial Officer |
2021-11-17 08:55:59 | 116,327 0 |
116,327 | Form 4 |
12 | Agwunobi John O Director |
2024-11-08 16:08:35 | 101,214 0 |
101,214 | Form 4 |
13 | Sterling O. James Chief Financial Officer |
2024-10-02 16:06:38 | 100,000 0 |
100,000 | Form 4 |
14 | DETORE JAMES M. Chief Financial Officer |
2014-12-03 09:19:09 | 100,000 0 |
100,000 | Form 4 |
15 | Vachon Mark Director |
2024-11-08 16:08:22 | 99,791 0 |
99,791 | Form 4 |
16 | Bain Linda VP, Fin. & Business Operations |
2014-03-05 17:04:24 | 99,532 0 |
99,532 | Form 4 |
17 | Tita-Reid Najoh Director |
2024-11-08 16:27:03 | 98,010 0 |
98,010 | Form 4 |
18 | Leiderman Elisabeth Director |
2024-11-08 16:08:28 | 97,006 0 |
97,006 | Form 4 |
19 | Jones-Burton Charlotte Director |
2024-11-08 16:08:44 | 93,312 0 |
93,312 | Form 4 |
20 | DIXON WENDY L Director |
2021-11-17 08:57:25 | 87,599 0 |
87,599 | Form 4 |
21 | Paulson Richard A. Director |
2024-11-08 16:08:53 | 79,413 0 |
79,413 | Form 4 |
22 | LYNCH DANIEL Director |
2021-11-17 08:57:05 | 77,801 0 |
77,801 | Form 4 |
23 | Whitten Jessica Chief Accounting Officer |
2022-02-03 18:08:02 | 71,913 0 |
71,913 | Form 4 |
24 | HIGH SUSANNA GATTI Chief Operating Officer |
2018-12-21 16:11:45 | 54,397 0 |
54,397 | Form 4/A |
25 | Walsh Jeffrey T. Chief Strategy Officer |
2019-08-21 16:06:02 | 50,442 0 |
50,442 | Form 4 |
26 | Davidson David Chief Medical Officer |
2021-04-07 16:42:47 | 47,787 0 |
47,787 | Form 4 |
27 | Eggimann Anne-Virginie Chief Regulatory Officer |
2022-07-14 16:15:49 | 42,252 0 |
42,252 | Form 4 |
28 | Finer Mitchell H. Chief Scientific Officer |
2015-06-03 11:53:26 | 40,000 0 |
40,000 | Form 4 |
29 | Cloonan Michael Director |
2024-10-02 16:06:32 | 37,350 0 |
37,350 | Form 4 |
30 | FINGER ALISON CECILY Chief Commercial Officer |
2021-01-08 17:57:09 | 25,103 0 |
25,103 | Form 4 |
31 | Sullivan Eric Principal Accounting Officer |
2017-08-07 16:02:19 | 21,704 300 |
22,004 | Form 4 |
32 | Smith-Farrell Joanne COO, Oncology |
2021-01-08 17:56:54 | 20,609 0 |
20,609 | Form 4 |
33 | Obenshain Andrew President and CEO |
2025-03-05 16:05:24 | 18,327 0 |
18,327 | Form 4 |
34 | Sellers William R. Director |
2021-11-17 08:58:36 | 15,087 0 |
15,087 | Form 4 |
35 | Schenkein David P Director |
2020-06-22 16:27:53 | 9,832 0 |
9,832 | Form 4 |
36 | WENTWORTH KORY JAMES Principal Accounting Officer |
2020-08-05 16:06:12 | 9,512 0 |
9,512 | Form 4 |
37 | MELTON DOUGLAS Director |
2020-06-22 16:27:48 | 9,324 0 |
9,324 | Form 4 |
38 | Torres Denice Director |
2021-11-17 08:55:27 | 8,632 0 |
8,632 | Form 4 |
39 | Klima Thomas J See Remarks |
2025-03-05 16:05:41 | 7,878 0 |
7,878 | Form 4 |
40 | Hedley Mary Lynne Director |
2018-06-22 16:21:14 | 7,700 0 |
7,700 | Form 4 |
41 | Colvin Richard A Chief Medical Officer |
2025-03-05 16:05:53 | 7,610 0 |
7,610 | Form 4 |
42 | MARAGANORE JOHN Director |
2017-09-18 16:09:23 | 5,843 0 |
5,843 | Form 4 |
43 | Vittiglio Joseph Chief Business & Legal Officer |
2025-02-05 16:14:57 | 4,501 0 |
4,501 | Form 4 |
44 | Burnett Katy Principal Accounting Officer |
2021-02-18 17:22:42 | 4,097 0 |
4,097 | Form 4 |
45 | Mandell James Director |
2018-09-12 16:07:32 | 1000 0 |
1000 | Form 4 |
46 | Glickman Sarah JS Director |
2021-11-17 08:56:15 | 0 0 |
0 | Form 4 |
47 | Maus Marcela V. Director |
2021-11-17 08:57:40 | 0 0 |
0 | Form 4 |
48 | Ibrahim Ramy Director |
2021-11-17 08:56:32 | 0 0 |
0 | Form 4 |
49 | THIRD ROCK VENTURES LP Third Rock Ventures GP L.P. TRV GP LLC 10% Owner |
2015-02-13 16:05:29 | 0 0 |
0 | Form 13G |
50 | Arch Venture Fund VII LP ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC BYBEE CLINTON CRANDELL KEITH NELSEN ROBERT 10% Owner |
2015-02-11 16:45:28 | 0 0 |
0 | Form 13G |